Page last updated: 2024-08-21

arsenic trioxide and Chronic Disease

arsenic trioxide has been researched along with Chronic Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, P; Belon, P; Bhattacharyya, SS; Khuda-Bukhsh, AR; Naoual, B; Pathak, S1
Batteux, F; Chéreau, C; Kavian, N; Laude, H; Marut, W; Nicco, C; Servettaz, A; Weill, B1
Akhand, AA; Emi, N; Hossain, K; Kajiguchi, T; Nakashima, I; Naoe, T; Saito, H; Yamamoto, K1
Chang, CS; Chen, YC; Chou, WC; Chung, CY; Huang, SF; Huang, SY; Kuo, TL; Shen, MC; Tang, JL; Tien, HF; Wang, CH; Yao, YT1
Aoyama, H; Kume, Y; Nagira, T; Tsuda, T; Yamamoto, M1

Other Studies

5 other study(ies) available for arsenic trioxide and Chronic Disease

ArticleYear
Comparative efficacy of two microdoses of a potentized homeopathic drug, arsenicum album, to ameliorate toxicity induced by repeated sublethal injections of arsenic trioxide in mice.
    Pathobiology : journal of immunopathology, molecular and cellular biology, 2008, Volume: 75, Issue:3

    Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Catalase; Chromosome Aberrations; Chronic Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glutathione; Lipid Metabolism; Male; Materia Medica; Mice; Mitotic Index; Oxides; Spermatozoa; Succinate Dehydrogenase; Transaminases; Treatment Outcome

2008
Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
    Journal of immunology (Baltimore, Md. : 1950), 2012, May-15, Volume: 188, Issue:10

    Topics: Animals; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Chronic Disease; Disease Models, Animal; Female; Fibrosis; Graft vs Host Disease; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxides; Random Allocation; Scleroderma, Systemic; Spleen

2012
Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.
    Leukemia, 2003, Volume: 17, Issue:11

    Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Chronic Disease; Enzyme Activation; Humans; Hydrogen Peroxide; Intracellular Membranes; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myeloid; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinases; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured

2003
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia.
    British journal of haematology, 1998, Volume: 103, Issue:4

    Topics: Acute Disease; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chronic Disease; Humans; Leukemia, Promyelocytic, Acute; Oxides; Recurrence

1998
[A case of lung cancer associated with chronic arsenic poisoning caused by neighborhood exposure of As2O3 from Toroku mine].
    Sangyo igaku. Japanese journal of industrial health, 1987, Volume: 29, Issue:3

    Topics: Aged; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Chronic Disease; Female; Humans; Lung Neoplasms; Mining; Occupational Diseases; Oxides

1987